Publications
-
Gallego A, Serrat M, Royuela-Colomer E, Sanabria JP, Borràs X, Esteve M, Grasa M, Rosa A, Rozadilla A, Almirall M, Francesco D'Amico, Dai Y, Rosenbluth MJ, McCracken LM, Navarrete J, Feliu A and Luciano JV.
Study protocol for a three-arm randomized controlled trial investigating the effectiveness, cost-utility, and physiological effects of a fully self-guided digital Acceptance and Commitment Therapy for Spanish patients with fibromyalgia.
Digital Health . 10: .
-
Colomer A, Sanabria JP, Hernández-Negrín H, Borràs X, Suso-Ribera C, García-Palacios A, Muchart-Lopez J, Munuera-del Cerro JL, Francesco D'Amico, Maes M, Younger JW, Feliu A, Rozadilla A and Luciano JV.
Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)
BMJ Open . 12(1): . Number of citations: 5
-
Luciano JV, Carlos Garcia Forero, Marta Cerdà Lafont, Peñarrubia-María MT, Fernández-Vergel R, JOSE MIGUEL RUIZ MARTIN, Rozadilla A, Sirvent Alierta, Elena, Santo Panero, Pilar, García Campayo, Javier, Serrano-Blanco A and Rubio-Valera M.
Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.
CLINICAL JOURNAL OF PAIN . 32(10): 829-840. Number of citations: 31